| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX31 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | TMEM132A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | TM4SF1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | DYRK3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | ELF2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | DYNC1LI1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | EMG1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | PPP1R13B | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | CAMK1D | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | CTC-435M10.3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
